Rational Pharmacotherapy in Cardiology

Rational Pharmacotherapy in Cardiology
影响因子:
0.3
ISSN:
print: 1819-6446
on-line: 2225-3653
研究领域:
CARDIAC & CARDIOVASCULAR SYSTEMS
自引率:
50.00%
Gold OA文章占比:
87.50%
原创研究文献占比:
95.56%
SCI收录类型:
Emerging Sources Citation Index (ESCI) || Scopus (CiteScore) || Directory of Open Access Journals (DOAJ)
期刊官网:
期刊介绍英文:
The primary goals of the Journal are consolidation of information on scientific and practical achievements in pharmacotherapy and prevention of cardiovascular diseases and continuing education of cardiologists and internists. The scientific concept of the edition suggests the publication of information on current achievements in cardiology, the results of national and international clinical trials. The Journal publishes original articles on the results of clinical trials designed to study the effectiveness and safety of drugs, analysis of clinical practice and its compliance with national and international recommendations, expert s’ opinions on a wide range of cardiology issues, associated conditions and clinical pharmacology. There is a heading “Preventive cardiology and public health” in the Journal to stimulate research interest in this highly demanded area. Memories of the outstanding people in medicine including cardiology, which are of great interest to historians of medicine, are published in "Our Mentors” heading.
CiteScore:
CiteScoreSJRSNIPCiteScore排名
1.00.1700.281
学科
排名
百分位
大类:Medicine
小类:Cardiology and Cardiovascular Medicine
304 / 387
21%
大类:Medicine
小类:Pharmacology (medical)
215 / 272
21%
发文信息
WOS期刊分区
学科分类
Q4CARDIAC & CARDIOVASCULAR SYSTEMS
历年影响因子
2022年0.2000
2023年0.3000
历年发表
2012年106
2013年103
2014年102
2015年99
2016年112
2017年118
2018年106
2019年112
2020年146
2021年104
2022年79
投稿信息
出版语言:
English, Russian
出版国家(地区):
Russian Federation
审稿时长:
6 weeks
出版商:
Stolichnaya Izdatelskaya Kompaniya

Rational Pharmacotherapy in Cardiology - 最新文献

Prognostic Significance of Echocardiographic Characteristics in Patients with Type 2 Myocardial Infarction: comparison with Type 1 Myocardial Infarction

Pub Date : 2023-11-07 DOI: 10.20996/1819-6446-2023-2940 T. H. Hoang, V. Maiskov, I. Merai, A. F. Safarova, Z. Kobalava

Pharmacogenetics and pharmacokinetics of rivaroxaban in patients with atrial fibrillation and chronic kidney disease

Pub Date : 2023-11-07 DOI: 10.20996/1819-6446-2023-2970 N. A. Shatalova, D. Sychev, K. Mirzaev, A. I. Kochetkov, E. Y. Ebzeeva, V. B. Dashabylova, P. Bochkov, S. N. Tuchkova, S. V. Glagolev

Changes of myocardial dysfunction and injury biomarkers over chemotherapy for multiple myeloma: difficulties in laboratory data interpretation

Pub Date : 2023-11-07 DOI: 10.20996/1819-6446-2023-2955 E. V. Fomina, S. A. Kardovskaya, D. A. Budanova, P. Markin, S. Appolonova, A. S. Lishuta, Y. Belenkov, I. Ilgisonis
查看全部
免责声明:
本页显示期刊或杂志信息,仅供参考学习,不是任何期刊杂志官网,不涉及出版事务,特此申明。如需出版一切事务需要用户自己向出版商联系核实。若本页展示内容有任何问题,请联系我们,邮箱:info@booksci.cn,我们会认真核实处理。
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信